IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
$29,701,453
| Recipient | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. UEI CNPVCR8DK7M8 |
|---|---|
| Award ID | HHSN272201400038C |
| Award amount | $29,701,453 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Aug 28, 2014 |
| End date | Jun 30, 2023 |
| Place of performance | GAITHERSBURG, MD |
| Record updated | May 19, 2022 |
View the official award record
More awards won by EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
IGF::OT::IGF
Department of Health and Human Services · $1,385,742,139 · Sep 30, 2016
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
Department of Health and Human Services · $529,216,465 · Aug 30, 2019
TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087
Department of Health and Human Services · $92,988,270 · Sep 17, 2010
MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN
Department of Health and Human Services · $59,974,026 · Jul 31, 2023
IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE
Department of Health and Human Services · $32,952,759 · Sep 15, 2017
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids